Clinical trial
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced…
NCT00426582 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00426582 |
|---|---|
| Title | Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors |
| Official title | A Phase Ib, Multicenter, Open-label, Dose-finding Study of Patupilone Administered Intravenously Every 3 Weeks in Combination With Carboplatin AUC 6 in Adult Patients With Advanced Solid Tumors |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Tumors |
| Intervention type | Drug |
| Interventions | Patupilone |
| Enrollment | 48 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2010 |
| First posted | Jan 25, 2007 |
| Last update posted | Dec 9, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: